231 related articles for article (PubMed ID: 15684604)
1. Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation.
Baker GL; Landis MW; Hinds PW
Cell Cycle; 2005 Feb; 4(2):330-8. PubMed ID: 15684604
[TBL] [Abstract][Full Text] [Related]
2. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
3. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
[TBL] [Abstract][Full Text] [Related]
4. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
5. G1 cyclins control the retinoblastoma gene product growth regulation activity via upstream mechanisms.
Horton LE; Qian Y; Templeton DJ
Cell Growth Differ; 1995 Apr; 6(4):395-407. PubMed ID: 7794807
[TBL] [Abstract][Full Text] [Related]
6. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.
Kato J; Matsushime H; Hiebert SW; Ewen ME; Sherr CJ
Genes Dev; 1993 Mar; 7(3):331-42. PubMed ID: 8449399
[TBL] [Abstract][Full Text] [Related]
7. Physical interaction of the retinoblastoma protein with human D cyclins.
Dowdy SF; Hinds PW; Louie K; Reed SI; Arnold A; Weinberg RA
Cell; 1993 May; 73(3):499-511. PubMed ID: 8490963
[TBL] [Abstract][Full Text] [Related]
8. NF-kappa B-dependent induction of cyclin D1 by retinoblastoma protein (pRB) family proteins and tumor-derived pRB mutants.
Takebayashi T; Higashi H; Sudo H; Ozawa H; Suzuki E; Shirado O; Katoh H; Hatakeyama M
J Biol Chem; 2003 Apr; 278(17):14897-905. PubMed ID: 12594215
[TBL] [Abstract][Full Text] [Related]
9. Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation.
Zwicker J; Brüsselbach S; Jooss KU; Sewing A; Behn M; Lucibello FC; Müller R
Oncogene; 1999 Jan; 18(1):19-25. PubMed ID: 9926916
[TBL] [Abstract][Full Text] [Related]
10. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation.
Connell-Crowley L; Harper JW; Goodrich DW
Mol Biol Cell; 1997 Feb; 8(2):287-301. PubMed ID: 9190208
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle-independent induction of D1 and D2 cyclin expression, but not cyclin-Cdk complex formation or Rb phosphorylation, by IFNgamma in macrophages.
Dey A; Li W
Biochim Biophys Acta; 2000 Jun; 1497(1):135-47. PubMed ID: 10838167
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation.
Skapek SX; Rhee J; Kim PS; Novitch BG; Lassar AB
Mol Cell Biol; 1996 Dec; 16(12):7043-53. PubMed ID: 8943359
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
[TBL] [Abstract][Full Text] [Related]
15. Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins.
Lasorella A; Iavarone A; Israel MA
Mol Cell Biol; 1996 Jun; 16(6):2570-8. PubMed ID: 8649364
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
Masamha CP; Benbrook DM
Cancer Res; 2009 Aug; 69(16):6565-72. PubMed ID: 19638577
[TBL] [Abstract][Full Text] [Related]
17. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
Lukas J; Müller H; Bartkova J; Spitkovsky D; Kjerulff AA; Jansen-Dürr P; Strauss M; Bartek J
J Cell Biol; 1994 May; 125(3):625-38. PubMed ID: 8175885
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
[TBL] [Abstract][Full Text] [Related]
19. The LxCxE pRb interaction domain of cyclin D1 is dispensable for murine development.
Landis MW; Brown NE; Baker GL; Shifrin A; Das M; Geng Y; Sicinski P; Hinds PW
Cancer Res; 2007 Aug; 67(16):7613-20. PubMed ID: 17699765
[TBL] [Abstract][Full Text] [Related]
20. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression.
Tam SW; Theodoras AM; Shay JW; Draetta GF; Pagano M
Oncogene; 1994 Sep; 9(9):2663-74. PubMed ID: 8058330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
